Avian erythroblastosis virus (AEV) induces erythroblastosis and fibrosarcomas. The viral erbB protein is required for AEV-mediated oncogenesis. To explore the structural aspects of the v-erbB polypeptide necessary for its oncogenic function, we created a series of small in-frame insertions in different domains of the v-erbB oncogene. AEV genomes bearing lesions within the v-erbB kinase domain demonstrated a drastically decreased ability to transform avian fibroblasts, establishing a functional role for this structurally conserved oncogene domain. In contrast, mutations in the extracellular domain, between the transmembrane region and the kinase domain, or at the extreme C terminus of the v-erbB protein had no effect on AEV-mediated fibroblast transformation. One lesion within the v-erbB kinase domain, a 10-amino acid insertion, produced a temperature-sensitive mutant capable of fibroblast transformation at 36°C but not at 41°C, suggesting that small in-frame insertions have general utility for the in vitro creation of conditional mutants.
Avian erythroblastosis virus (AEV) is a retrovirus that induces fibrosarcomas and erythroblastosis in susceptible birds and transforms fibroblasts and erythroid cells in culture to an oncogenic state (9, 14, 22) . A single genetic locus within the AEV genome, v-erbB, is required for oncogenic transformation of cells of either linkeage and appears to suffice for tumorigenicity (10, 36, 37) . The primary translation product of the v-erbB gene is a 61,000-molecular-weight polypeptide (p6lv-erbB) which is glycosylated in AEV- infected cells to yield several species of higher apparent molecular weight (principally gp65v erbB, gp68v erbB, and gp73v-erbB) (4, 18, 19, 30, 31, 33) . v-erbB-encoded polypeptide species are tightly associated with membranes in infected cells and appear to be synthesized in the rough endoplasmic reticulum, from which they are translocated to smooth and plasma membrane fractions (4, 18, 31) .
The amino acid sequence of the v-erbB protein has been determined from the nucleic acid sequence of the molecularly cloned v-erbB gene (32, 44 ; M. L. Privalsky, unpublished data). This predicted amino acid sequence, together with biochemical characterizations of the v-erbB protein itself, suggest that the v-erbB polypeptide is a transmembrane protein, with the (probably glycosylated) N terminus exposed on the extracellular surface of the AEVinfected cell (18, 19, 44) . A short transmembrane domain of 23 hydrophobic amino acids follows this external domain and is followed in turn by an intracellular region structurally related to the catalytic domains found in the tyrosine-specific protein kinase family of oncogene proteins ( Fig. 1) (32, 44) . However, the external, transmembrane, and extreme Cterminal domains of the v-erbB protein lack demonstrable sequence relatedness to any other known viral oncogene polypeptides (44; M. L. Privalsky, unpublished data).
The AEV erbB gene probably represents a virally transduced copy of the host-cell gene for epidermal growth factor receptor (EGF receptor) (8, 26, 40) . The EGF receptor is involved in the regulation of growth and proliferation in many normal, uninfected cells (see reference 20 for a re-* Corresponding author. view). The viral erbB gene represents a truncated copy of the full-length cellular gene, lacking coding sequences for both N-terminal EGF-binding and C-terminal phosphorylation sites that are present in the normal EGF receptor (26, 40) . The absence of these potential regulatory sequences in the v-erbB protein may result in aberrant expression and may therefore account for the oncogenic properties of AEV (7, 11, 24, 27, 40) .
To better understand the relationship between the structural features, biochemical properties, and oncogenic abilities of the v-erbB protein, we generated a series of in-frame insertions in different regions of the v-erbB coding domain. We subsequently tested the effect of these genetic lesions on the ability of the v-erbB protein to transform avian fibroblasts. We found by this method that the structural integrity of the kinase domain is essential for the ability of the v-erbB protein to transform fibroblasts, demonstrating a functional role for this highly conserved amino acid sequence. In contrast, both C and N termini of the v-erbB protein can sustain mutations without apparent effect on fibroblasttransforming ability. Our mutagenesis scheme also allowed us to isolate a defined genetic lesion in the v-erbB gene that yields a temperature-sensitive transformation phenotype, suggesting that this form of mutagenesis may be of general use in the creation and analysis of conditional mutants.
MATERIALS AND METHODS
Virus and cells. A stock of the AEV ES-4 strain was generously provided by Thomas Graf and was used as a reference positive control for our biological assays of the AEV-transformed phenotype. Chicken secondary cell cultures consisting mainly of fibroblasts were established from 10-to 12-day-old embryos (SPAFAS flock, C/E or C/O). Both infected and uninfected chicken fibroblasts were maintained in medium 199 (GIBCO Laboratories, Grand Island, N.Y.) supplemented with 10% tryptose phosphate broth, 5% bovine serum, 1% heat-inactivated chicken serum, and antibiotics (1 mg of streptomycin per ml, 100 U of penicillin per ml, 2.5 ,ug of amphotericin B per ml), using a 0.2% bicarbonate-5% Regions of possible N-linked glycosylation (CHO), the putative transmembrane domain, and the region bearing amino acid sequence relatedness to the tyrosine-specific kinase family of oncogene proteins (kinase-domain) are indicated. Also indicated (by circled letters) are a threonine in the v-erbB sequence that may be phosphorylated by protein kinase C (T), a lysine that may represent a portion of the ATP-binding site for the kinase (K), and a tyrosine that can be autophosphorylated in c-erbB (Y) (7, 17, 21) . Arrows point to AluI restriction sites in the v-erbB gene. In this and subsequent figures, the AluI site numbers refer to position of the cleavage site (in base pairs) from the first base of the first methionine codon in the AEV strain ES-4 v-erbB open reading frame. The corresponding positions in the numbering system published for the AEV strain H v-erbB nucleotide sequence (44) (36, 37, 42) . This infectious plasmid clone (referred to as pAEV-11-3) contains two EcoRI restriction endonuclease sites (37) . To facilitate manipulation of the plasmid and reconstruction of our mutated subclones into an infectious form, we eliminated the leftmost EcoRI site from the pAEV-11-3 plasmid by partial digestion with EcoRI, followed by fill-in with Klenow fragment and religation. This process generated the plasmid pAEV-11-3R (containing unique SalI and EcoRI sites bracketing the v-erbB gene) (Fig. 2) .
A subclone of the AEV 2.3-kilobase SalI-EcoRI fragment containing the v-erbB gene was constructed in pBR322 (pAE-SalRI; Fig. 2 ) and served as the actual substrate for site-directed mutagenesis, permitting us to mutagenize the v-erbB gene in the absence of large amounts of extraneous DNA sequences.
Insertional mutagenesis. We used essentially the procedure of Stone et al. (39) for insertional mutagenesis. Individual molecules of the pAE-SaIRI plasmid were linearized at different AluI sites by employing ethidium bromide to limit the restriction endonuclease cleavage reaction (29) . The optimal concentration of ethidium bromide was determined empirically: a series of tubes containing supercoiled pAESalRI DNA, an excess of AluI, and increasing amounts of ethidium bromide was prepared ( (33) . The cells were lysed, and the radiolabeled proteins were analyzed by immunoprecipitation, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Antiserum to a bacterially synthesized segment of the v-erbB protein (anti-bp28verbB) was prepared as detailed previously (33) . RESULTS Set of in-frame insertion mutations created in the v-erbB coding region. We employed a method of site-directed mutagenesis on the v-erbB gene that has demonstrated great promise in other systems: the creation of a series of small, in-frame insertion mutations (39) . DNA sequence analysis revealed that there were nine well-distributed AluI restriction endonuclease sites within the molecularly cloned AEV strain ES-4 v-erbB gene ( Fig. 1 ; the corresponding sites in the closely related AEV strain H v-erbB gene are also indicated in the figure legend to permit comparison with our ES-4 strain sequence). We therefore used a partial AluIethidium bromide digestion to linearize a supercoiled plasmid subclone of the v-erbB gene (Fig. 2) . We then recircularized the plasmid population in the presence of an excess of hexanucleotide linkers (pGTTAAC). Each hexanucleotide linker introduced in this fashion generated an in-frame insertion at a former AluI site and introduced a novel HpaI recognition sequence at the point of insertion (Fig. 2) . Recombinant plasmids bearing HpaI linker insertions at different sites in the v-erbB coding domain were identified, subcloned, and propagated.
We were able to isolate eight of the nine possible AluI site insertions (insertions at AluI site 843 were not detected). Of 140 mutagenized plasmid clones analyzed, 54 contained linker insertions in AluI sites in the v-erbB coding region, 4 contained insertions in an AluI site upstream of the v-erbB coding region (a site not shown in Fig. 1 Fibroblast transformation by AEV bearing v-erbB insertion mutations: substrate-independent growth. The v-erbB insertion mutations, created within the pAE-SalRI subclone, were subsequently reconstructed into an infectious form (pAEV-11-3R; Fig. 2 ). The pAEV-11-3R plasmid contains a complete AEV DNA genome, colinear with the viral RNA genome (36, 37 Fibroblasts transfected with the various v-erbB insertion mutants, with the RAV-1 helper virus alone, or with reconstructed wild-type AEV were first tested for the ability to form colonies in soft-agar medium. Substrate-independent growth is a fairly stringent criterion of oncogenic transformation: normal fibroblasts are unable to propagate in agar suspension, whereas fibroblasts transformed by a number of different agents, including wild-type AEV, are able to replicate and form macroscopic colonies (3, 10, 14, 34, 37) .
The results of this assay for the polylinker series of insertion mutations are illustrated in Fig. 3 and 4 . Representative microscopic fields of soft-agar plates seeded with cells transfected by the different AEV mutants are shown in Fig.  3 . These data are represented quantitatively in Fig. 4 . Fibroblasts transfected by wild-type AEV yielded large colonies containing several hundred cells each under these assay conditions (39°C for 2 weeks), whereas fibroblasts transfected by RAV-1 alone failed to give rise to any observable colonies. Viruses with insertional mutations in the extracellular domain of the v-erbB protein (Alu 117) and between the transmembrane domain and the kinase domain (Alu 321) retained full ability to transform fibroblasts by this assay, giving rise to colonies virtually identical in number and morphology to those induced by wild-type v-erbB. The same was true of insertions at two sites in the C terminus of the v-erbB coding region (Alu 1476 and Alu 1554). On the other hand, two different mutants bearing insertional lesions in the kinase domain of the v-erbB protein (at Alu 621 and Alu 1149) failed to transform fibroblasts by this criterion, giving rise to drastically reduced numbers of macroscopic colonies (Fig. 4, solid bars) . The Alu 424-T insertion introduced a nonsense codon into the v-erbB sequence; this mutant, as expected, also failed to transform cells ( Fig. 3 and  4) .
Microscopic examination of these soft-agar cultures revealed that although the Alu 621 mutant yielded few macroscopic colonies (colonies of over 100 cells each), this mutant did yield significant numbers of very small colonies of approximately 10 to 20 cells each (Fig. 3 and Fig. 4 , dashed bars). This intermediate phenotype at the 39°C assay temperature is due to a temperature-sensitive lesion, as will be discussed in detail later.
Other criteria of fibroblast transformation: hexose uptake. (Fig. 1) . The linker insertion into the Alu 424 site generates an ochre nonsense codon and a prematurely terminated v-erbB protein (Alu 424-T).
Avian fibroblasts transformed by wild-type AEV demonstrate elevated levels of hexose transport (3, 28, 34) . We therefore assayed fibroblasts transfected by our various AEV v-erbB polylinker insertion mutants for this manifestation of the transformed state (Fig. 5) . Fibroblasts transfected by a reconstructed wild-type AEV demonstrated levels of 2-deoxyglucose uptake almost 16-fold greater than those of fibroblasts transfected by helper virus alone. Cells transfected by AEV mutants that were positive in the soft-agar colony assay (AluI sites 117, 321, 1476, and 1554; Fig. 5 , solid bars) also possessed high levels of hexose uptake (9-to 14-fold elevated over those of fibroblasts transfected by RAV-1 only). In contrast, fibroblasts transfected by the mutants that were negative in the soft-agar assay (AluI sites Fibroblasts transfected by the different AEV v-erbB insertion mutants were seeded into soft-agar medium as described in Materials and Methods (10,000 cells per 60-mm culture dish), and the number of cell colonies appearing after 2 weeks at 39°C was determined. The number of fibroblast colonies induced by each AEV insertion mutant is plotted relative to the position of the mutation in the v-erbB coding region in base pairs from the beginning of the coding region (below) and relative to a schematic of the v-erbB protein (above). Solid lines, Number of large, macroscopic fibroblast colonies; dashed lines, number of small, microscopic fibroblast colonies (see Fig. 3 (Fig. 5 ). This general pattern was consistent from assay to assay, with cells from different embryos. These results indicate that even the mutants that are unable to mediate substrate-independent growth may still exert a measurable effect on the phenotype of the transformed cell, perhaps owing to leakiness or to some other phenomenon. This partially transformed phenotype was also observed in the plasminogen activator assay (see below).
Other criteria of oncogenic transformation: plasminogen activator production. Another phenotypic trait that is often associated with oncogenic transformation of fibroblasts is an elevated level of production and secretion of plasminogen activator protease (12) . We assayed fibroblasts transfected by the different AEV mutants for protease expression with a casein-agar overlay technique in which the number of sistently demonstrating plasminogen activator levels at 39°C slightly greater than those of helper virus alone.
Polylinker insertions at AluI site 621 yield a temperaturesensitive phenotype. As previously indicated, we noted that certain of the insertion mutations in v-erbB, particularly those at the Alu 621 site, yielded an intermediate transformed phenotype in a number of different assays performed at 39°C (colony formation in soft agar, deoxyglucose uptake, and plasminogen activator protease secretion). In at least one other system, small in-frame insertion mutations yielded temperature-sensitive protein products (5). Our polylinker mutants with an intermediate phenotype at 39°C were therefore reassayed at both 36 and 42°C. Polylinker insertions into the Alu 621 site yielded a strongly temperature-sensitive phenotype, producing soft-agar colonies comparable in size, morphology, and number to those of wild-type AEV when assayed at the permissive temperature (36°C) but yielding few or no colonies at the nonpermissive temperature (42°C) (Fig. 6) . We observed the same temperature-sensitive phenotype in fibroblasts transfected by a second, independently derived Alu 621 polylinker insertion mutant (data not shown). Deoxyglucose uptake of fibroblasts transfected by the Alu 621 polylinker mutants also demonstrated temperature sensitivity. When fibroblasts transfected by these mutants were maintained at 36°C for 1 week before assay, they consistently exhibited hexose uptake rates two-to threefold greater than those of the same cells maintained at 41°C ( Table 2 ). The levels of 2-deoxyglucose uptake exhibited by the Alu 621 mutant at 36°C were comparable to those of cells transfected by wild-type AEV ( (3, 000 Ci/mmol). The cells were then washed and lysed, and the erb-related polypeptides were immunoprecipitated as previously described (33) . The immunoprecipitates were analyzed by electrophoresis through a sodium dodecyl sulfate-8% polyacrylamide gel, and the radiolabeled proteins were visualized by autoradiography. The positions on the autoradiogram of the major v-erbB protein species synthesized by wildtype AEV during this 2-h pulse-label (65,000 and 68,000 in apparent molecular weight) are indicated. RAV Proviruses and v-erbB expression in fibroblasts transfected by AEV insertion mutants. A trivial explanation of our results would be that certain of our insertion mutants could not infect avian fibroblasts or were unable to express wild-type levels of a stable v-erbB protein. We also wished to ensure that the phenotypes of the fibroblast cultures analyzed were truly due to the AEV mutant introduced and not due to accidental cross-contamination with wild-type AEV or due to some revertant event. We therefore performed a Southern analysis of each of the mutant-transfected fibroblast lines, cleaving the genomic DNA with HpaI and a number of other restriction endonucleases and analyzing the resulting gel blots with erb-specific probes (data not shown). In all cases, the fibroblasts contained integrated AEV proviruses, and these proviruses possessed a genomic structure identical to that of the AEV mutant originally introduced, with no evidence of wild-type viral contamination or detectable proviral rearrangements.
Although Southern analysis confirmed the infectivity and genetic arrangement of our mutant AEVs, it did not address the issue of whether the v-erbB gene was expressed. We therefore analyzed the v-erbB proteins synthesized by our mutants, utilizing an immunoprecipitation-sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis (Fig. 7) . With the exception of the Alu 424-T nonsense mutant, all of the mutant viruses synthesized v-erbB protein at levels comparable to or greater than that of wild-type AEV (the gp65v-erbB and gp68v-erbB polypeptides were the predominant species produced during this 2-h pulse-label). The Alu 424-T insertion should produce a prematurely terminated v-erbB polypeptide of approximately 14,000 molecular weight. Unfortunately, our antisera were not reactive against this N-terminal peptide fragment (33), and we did not detect this prematurely terminated v-erbB protein in our immunoprecipitates. The v-erbB proteins synthesized by our insertion mutants varied slightly in apparent molecular weight from one another and from the wild-type polypeptide, probably owing to the variable number of linker multimers present in the different mutants (four to nine per AluI site).
Analysis of single-linker insertion mutants. The initial genetic lesions created by our mutagenesis scheme consisted of the insertion of multiple, in-frame hexanucleotide linkers at each AluI site (from four to nine linkers, introducing 8 to 18 amino acids into the mutated protein). We desired to reanalyze the effects of these genetic lesions in the context of smaller, single-linker insertions (dipeptide insertions). We therefore digested each of our polylinker insertion mutations to completion with HpaI (removing the extra linkers) and religated the DNA molecules. These single-linker insertion mutations were then reconstructed into an infectious form and transfected into avian fibroblasts, and the cells were characterized for the transformed phenotype as described n--Li above for the polylinker insertions. The results are indicated in Fig. 8 and Table 3 . In general, the results with the single-linker insertions were identical to those already obtained with polylinkers: mutants bearing insertions in the extracellular domain of the v-erbB protein, between the transmembrane site and the kinase domain, and in the C-terminal portion of the v-erbB coding domain were fully capable of transforming fibroblasts. These results provide an independent confirmation of the data obtained with the polylinker insertions. Single dipeptide insertions at the Alu 424-T and Alu 1149 sites were unable to transform fibroblasts, a property shared with polylinker insertion mutations at these same sites.
One striking exception was noted from this general pattern. Fibroblasts transfected by AEV bearing a single-linker insertion at the Alu 621 site were fully capable of substrateindependent growth in soft agar at 39°C (Fig. 8) , whereas AEV bearing a polylinker insertion at this same v-erbB site possessed a strongly temperature-sensitive phenotype. Fibroblasts transfected by the Alu 621 single-linker insertion mutant also demonstrated a relatively high hexose transport when grown at 39°C (Table 3 ). It appears that a small insertion at this region of the kinase domain does not seriously disrupt the conformation of the v-erbB protein, whereas a larger insertion may destabilize this region sufficientJy to make it thermolabile. Fibroblasts transfected by the Alu 621 single-linker mutant retained the low levels of expression of plasminogen activator exhibited by the polylinker mutant at the same site ( The Alu 321 linker insertion is located between the transmembrane site of the v-erbB protein and the beginning of the kinase-like domain (Fig. 1 ). It appears that even large insertions in this region do not diminish the ability of the v-erbB protein to transform avian fibroblasts. Apparently an exact distance between the kinase-like region and the plasma membrane is not critical for activity. A corresponding region of the Fujinami virus fps oncogene protein can also sustain large insertions without loss of function (39) . Perhaps this domain of the tyrosine-specific protein kinases serves simply as a spacer to extend the "catalytic" kinase domain away from the lipid bilayer.
The Alu 321 insertion in the v-erbB protein is located nine codons downstream from an amino acid (Thr 98 in the viral protein) that may be a target of protein kinase C phosphorylation. Phosphorylation of a conserved threonine in the same region of the cellular EGF receptor inhibits the kinase activity of the receptor, suggesting that this threonine site is involved in modulation of the activity of the c-erbB (EGF receptor) protein (21) . We did not, however, note any phenotypic consequences resulting from our mutagenesis near this potential regulatory site: the Alu 321 mutant transformed fibroblasts in a manner indistinguishable from that of wild-type AEV.
An in-frame insertion in the extracellular domain of the v-erbB protein (Alu 117) also failed to affect the ability of this protein to transform avian fibroblasts. This mutation, located in the center of three possible sites of protein glycosylation, also had no visible effect on the glycosylation state of the v-erbB protein during a 2-h pulse-label (Fig. 7) . We have recently created a deletion mutation of the v-erbB protein that removes 52 amino acids of the extracellular domain (including the Alu 117 site and all three possible glycosylation sites). This deletion mutation produces an unglycosylated v-erbB protein that appears to function normally in oncogenic transformation of both fibroblasts and erythroid cells (M. Bassiri and M. L. Privalsky, manuscript in preparation). It would therefore appear that much of the extracellular domain of the v-erbB protein is not required for activity and may simply represent a fossil remnant of the transduction event that created the v-erbB protein from the cellular EGF receptor.
Requirement of the kinase-like domain of the v-erbB protein for fibroblast transformation. Insertions in the central third of the v-erbB coding region resulted in a severely diminished ability of the virus to transform fibroblasts. These transformation-defective genetic lesions were in a region of the v-erbB protein that demonstrates a strong amino acid sequence relatedness to domains found in the tyrosine-directed protein kinase family of viral oncogene polypeptides (as typified by the Rous sarcoma virus src protein [32, 44] ). This highly conserved amino acid sequence is thought to define a portion of the catalytic site of these protein kinases (6, 17) , an observation consistent with recent demonstrations of a tyrosine-directed protein kinase activity associated with the AEV v-erbB protein (11, 24) . Our site-directed mutagenesis represents the first demonstration that the structural integrity of this kinase-like domain is essential for the ability of the v-erbB protein to transform avian fibroblasts, indicating that the mechanism of action of the v-erbB oncogene in fibroblasts may be closely related to that of other members of the src family. We are presently assaying our different v-erbB mutants for in vitro kinase activity (11 (35) . This technique, applied in a site-specific manner, may also permit temperaturesensitive effects to be directed toward a particular function of a multidomain polypeptide (the catalytic or regulatory domains of growth factor receptors, for example). In addition, systematic alteration of the size and nature of the insertion may allow better understanding of criteria operating in the establishment and maintenance of protein conformation.
